Sonesitatug vedotin

DRUG2 trials

Sponsors

Jeeyun Lee, AstraZeneca

Conditions

Esophageal CancerGastric CancerGastroesophageal Junction AdenocarcinomaStomach Neoplasms

Phase 2

Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer

RecruitingNCT06630130

Jeeyun LeeStomach Neoplasms

Start: 2025-01-22End: 2029-06-30Target: 100Updated: 2026-07-01

Phase 3

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

RecruitingNCT07431281

AstraZenecaEsophageal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

Start: 2026-02-03End: 2031-10-27Target: 2130Updated: 2026-07-01